Filter by: patients
Home > Community Treatment Reports and Side Effects > Diflunisal Treatment Report
What is Diflunisal?

Diflunisal is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of inflammatory disorders usually including rheumatoid arthritis and osteoarthritis; can be used as an analgesic for treatment of mild-to-moderate pain.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Pain 4 1 Efficacy_major
Fibromyalgia 4 3 Efficacy_major Efficacy_none
Inflammation 4 1 Efficacy_major
Ankylosing Spondylitis 1 0

See all 5 patients currently taking Diflunisal

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 2
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Diflunisal

Indigestion 1

Reported Dosages

  1,000 mg daily
  5 Number of Patients: 5  

Reported Stop Reasons

Why Patients Stopped Taking Diflunisal (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 2   Did not seem to work: 100%

See all 2 patients who’ve stopped taking Diflunisal

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Diflunisal

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Diflunisal

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Diflunisal

Always
 2 67%
Usually
 0 0%
Sometimes
 1 33%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Diflunisal

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 3 100%

Cost

Paid out of pocket

Cost of Diflunisal

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 26, 2012.